nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CYP3A4—bone cancer	0.862	1	CbGaD
Isradipine—CACNA1S—pes—bone cancer	0.0153	0.758	CbGeAlD
Isradipine—CACNA1S—tendon—bone cancer	0.00117	0.058	CbGeAlD
Isradipine—Clevidipine—CYP3A4—bone cancer	0.00102	0.133	CrCbGaD
Isradipine—Nisoldipine—CYP3A4—bone cancer	0.000981	0.127	CrCbGaD
Isradipine—Nimodipine—CYP3A4—bone cancer	0.000948	0.123	CrCbGaD
Isradipine—Nilvadipine—CYP3A4—bone cancer	0.000918	0.119	CrCbGaD
Isradipine—Nitrendipine—CYP3A4—bone cancer	0.000918	0.119	CrCbGaD
Isradipine—CACNA2D2—spinal cord—bone cancer	0.000889	0.0439	CbGeAlD
Isradipine—CACNA1C—connective tissue—bone cancer	0.000828	0.041	CbGeAlD
Isradipine—Amlodipine—CYP3A4—bone cancer	0.00079	0.102	CrCbGaD
Isradipine—Felodipine—CYP3A4—bone cancer	0.00073	0.0947	CrCbGaD
Isradipine—Eye disorder—Cisplatin—bone cancer	0.000708	0.00645	CcSEcCtD
Isradipine—Nifedipine—CYP3A4—bone cancer	0.000706	0.0916	CrCbGaD
Isradipine—CACNB2—tendon—bone cancer	0.000706	0.0349	CbGeAlD
Isradipine—Cardiac disorder—Cisplatin—bone cancer	0.000703	0.00641	CcSEcCtD
Isradipine—Flushing—Cisplatin—bone cancer	0.000703	0.00641	CcSEcCtD
Isradipine—Nicardipine—CYP3A4—bone cancer	0.000695	0.0902	CrCbGaD
Isradipine—Polyuria—Methotrexate—bone cancer	0.000684	0.00624	CcSEcCtD
Isradipine—Immune system disorder—Cisplatin—bone cancer	0.000684	0.00624	CcSEcCtD
Isradipine—Mediastinal disorder—Cisplatin—bone cancer	0.000683	0.00622	CcSEcCtD
Isradipine—Fluid retention—Doxorubicin—bone cancer	0.000681	0.0062	CcSEcCtD
Isradipine—CACNA2D1—tendon—bone cancer	0.000663	0.0328	CbGeAlD
Isradipine—Malnutrition—Cisplatin—bone cancer	0.000659	0.00601	CcSEcCtD
Isradipine—CACNA2D1—bone marrow—bone cancer	0.000642	0.0317	CbGeAlD
Isradipine—Visual disturbance—Methotrexate—bone cancer	0.000634	0.00578	CcSEcCtD
Isradipine—Muscle spasms—Cisplatin—bone cancer	0.000634	0.00578	CcSEcCtD
Isradipine—Vision blurred—Cisplatin—bone cancer	0.000621	0.00566	CcSEcCtD
Isradipine—Cerebrovascular accident—Methotrexate—bone cancer	0.000613	0.00559	CcSEcCtD
Isradipine—Lethargy—Methotrexate—bone cancer	0.000613	0.00559	CcSEcCtD
Isradipine—Ill-defined disorder—Cisplatin—bone cancer	0.000612	0.00558	CcSEcCtD
Isradipine—Anaemia—Cisplatin—bone cancer	0.00061	0.00556	CcSEcCtD
Isradipine—Malaise—Cisplatin—bone cancer	0.000595	0.00542	CcSEcCtD
Isradipine—Leukopenia—Cisplatin—bone cancer	0.00059	0.00538	CcSEcCtD
Isradipine—Cardiac failure—Epirubicin—bone cancer	0.000576	0.00525	CcSEcCtD
Isradipine—Lethargy—Epirubicin—bone cancer	0.000574	0.00523	CcSEcCtD
Isradipine—Cerebrovascular accident—Epirubicin—bone cancer	0.000574	0.00523	CcSEcCtD
Isradipine—Pain in extremity—Epirubicin—bone cancer	0.000562	0.00513	CcSEcCtD
Isradipine—Anxiety—Cisplatin—bone cancer	0.000559	0.0051	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000558	0.00508	CcSEcCtD
Isradipine—Liver function test abnormal—Methotrexate—bone cancer	0.000555	0.00506	CcSEcCtD
Isradipine—Discomfort—Cisplatin—bone cancer	0.000555	0.00506	CcSEcCtD
Isradipine—Breast disorder—Methotrexate—bone cancer	0.000543	0.00495	CcSEcCtD
Isradipine—Anaphylactic shock—Cisplatin—bone cancer	0.000538	0.00491	CcSEcCtD
Isradipine—Oedema—Cisplatin—bone cancer	0.000538	0.00491	CcSEcCtD
Isradipine—Cardiac failure—Doxorubicin—bone cancer	0.000533	0.00486	CcSEcCtD
Isradipine—Lethargy—Doxorubicin—bone cancer	0.000531	0.00484	CcSEcCtD
Isradipine—Cerebrovascular accident—Doxorubicin—bone cancer	0.000531	0.00484	CcSEcCtD
Isradipine—Nervous system disorder—Cisplatin—bone cancer	0.000528	0.00481	CcSEcCtD
Isradipine—Thrombocytopenia—Cisplatin—bone cancer	0.000527	0.0048	CcSEcCtD
Isradipine—Tachycardia—Cisplatin—bone cancer	0.000525	0.00479	CcSEcCtD
Isradipine—Skin disorder—Cisplatin—bone cancer	0.000523	0.00476	CcSEcCtD
Isradipine—Pain in extremity—Doxorubicin—bone cancer	0.00052	0.00474	CcSEcCtD
Isradipine—Hyperhidrosis—Cisplatin—bone cancer	0.00052	0.00474	CcSEcCtD
Isradipine—Liver function test abnormal—Epirubicin—bone cancer	0.000519	0.00473	CcSEcCtD
Isradipine—Breast disorder—Epirubicin—bone cancer	0.000508	0.00463	CcSEcCtD
Isradipine—Hypotension—Cisplatin—bone cancer	0.000503	0.00458	CcSEcCtD
Isradipine—Abdominal discomfort—Methotrexate—bone cancer	0.000498	0.00454	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00049	0.00447	CcSEcCtD
Isradipine—Paraesthesia—Cisplatin—bone cancer	0.000483	0.0044	CcSEcCtD
Isradipine—Liver function test abnormal—Doxorubicin—bone cancer	0.00048	0.00438	CcSEcCtD
Isradipine—Dyspnoea—Cisplatin—bone cancer	0.00048	0.00437	CcSEcCtD
Isradipine—Erectile dysfunction—Methotrexate—bone cancer	0.000478	0.00436	CcSEcCtD
Isradipine—Photosensitivity reaction—Methotrexate—bone cancer	0.000474	0.00432	CcSEcCtD
Isradipine—Angina pectoris—Epirubicin—bone cancer	0.000473	0.00432	CcSEcCtD
Isradipine—Breast disorder—Doxorubicin—bone cancer	0.00047	0.00429	CcSEcCtD
Isradipine—Decreased appetite—Cisplatin—bone cancer	0.000468	0.00426	CcSEcCtD
Isradipine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000465	0.00424	CcSEcCtD
Isradipine—Drowsiness—Methotrexate—bone cancer	0.000463	0.00422	CcSEcCtD
Isradipine—Depression—Methotrexate—bone cancer	0.000462	0.00421	CcSEcCtD
Isradipine—Pollakiuria—Epirubicin—bone cancer	0.000449	0.00409	CcSEcCtD
Isradipine—Photosensitivity reaction—Epirubicin—bone cancer	0.000444	0.00404	CcSEcCtD
Isradipine—Feeling abnormal—Cisplatin—bone cancer	0.000444	0.00404	CcSEcCtD
Isradipine—Weight increased—Epirubicin—bone cancer	0.000442	0.00403	CcSEcCtD
Isradipine—Angina pectoris—Doxorubicin—bone cancer	0.000438	0.00399	CcSEcCtD
Isradipine—Hepatobiliary disease—Methotrexate—bone cancer	0.000438	0.00399	CcSEcCtD
Isradipine—Drowsiness—Epirubicin—bone cancer	0.000433	0.00395	CcSEcCtD
Isradipine—Hepatitis—Methotrexate—bone cancer	0.000416	0.00379	CcSEcCtD
Isradipine—Pollakiuria—Doxorubicin—bone cancer	0.000415	0.00379	CcSEcCtD
Isradipine—Urinary tract disorder—Methotrexate—bone cancer	0.000411	0.00374	CcSEcCtD
Isradipine—Photosensitivity reaction—Doxorubicin—bone cancer	0.00041	0.00374	CcSEcCtD
Isradipine—Hepatobiliary disease—Epirubicin—bone cancer	0.00041	0.00374	CcSEcCtD
Isradipine—Weight increased—Doxorubicin—bone cancer	0.000409	0.00373	CcSEcCtD
Isradipine—Urethral disorder—Methotrexate—bone cancer	0.000408	0.00371	CcSEcCtD
Isradipine—Drowsiness—Doxorubicin—bone cancer	0.000401	0.00365	CcSEcCtD
Isradipine—Visual impairment—Methotrexate—bone cancer	0.000401	0.00365	CcSEcCtD
Isradipine—Bradycardia—Epirubicin—bone cancer	0.000396	0.00361	CcSEcCtD
Isradipine—Hepatitis—Epirubicin—bone cancer	0.000389	0.00355	CcSEcCtD
Isradipine—Eye disorder—Methotrexate—bone cancer	0.000388	0.00354	CcSEcCtD
Isradipine—Hypoaesthesia—Epirubicin—bone cancer	0.000387	0.00353	CcSEcCtD
Isradipine—Asthenia—Cisplatin—bone cancer	0.000386	0.00352	CcSEcCtD
Isradipine—Cardiac disorder—Methotrexate—bone cancer	0.000386	0.00352	CcSEcCtD
Isradipine—Urinary tract disorder—Epirubicin—bone cancer	0.000384	0.0035	CcSEcCtD
Isradipine—Oedema peripheral—Epirubicin—bone cancer	0.000383	0.00349	CcSEcCtD
Isradipine—Connective tissue disorder—Epirubicin—bone cancer	0.000382	0.00348	CcSEcCtD
Isradipine—Urethral disorder—Epirubicin—bone cancer	0.000381	0.00348	CcSEcCtD
Isradipine—Hepatobiliary disease—Doxorubicin—bone cancer	0.000379	0.00346	CcSEcCtD
Isradipine—Angiopathy—Methotrexate—bone cancer	0.000377	0.00344	CcSEcCtD
Isradipine—Immune system disorder—Methotrexate—bone cancer	0.000375	0.00342	CcSEcCtD
Isradipine—Visual impairment—Epirubicin—bone cancer	0.000375	0.00342	CcSEcCtD
Isradipine—Mediastinal disorder—Methotrexate—bone cancer	0.000375	0.00341	CcSEcCtD
Isradipine—Diarrhoea—Cisplatin—bone cancer	0.000368	0.00336	CcSEcCtD
Isradipine—Bradycardia—Doxorubicin—bone cancer	0.000366	0.00334	CcSEcCtD
Isradipine—Mental disorder—Methotrexate—bone cancer	0.000364	0.00332	CcSEcCtD
Isradipine—Eye disorder—Epirubicin—bone cancer	0.000364	0.00331	CcSEcCtD
Isradipine—Malnutrition—Methotrexate—bone cancer	0.000362	0.0033	CcSEcCtD
Isradipine—Cardiac disorder—Epirubicin—bone cancer	0.000361	0.00329	CcSEcCtD
Isradipine—Flushing—Epirubicin—bone cancer	0.000361	0.00329	CcSEcCtD
Isradipine—Hepatitis—Doxorubicin—bone cancer	0.00036	0.00328	CcSEcCtD
Isradipine—Hypoaesthesia—Doxorubicin—bone cancer	0.000358	0.00326	CcSEcCtD
Isradipine—Urinary tract disorder—Doxorubicin—bone cancer	0.000355	0.00324	CcSEcCtD
Isradipine—Oedema peripheral—Doxorubicin—bone cancer	0.000355	0.00323	CcSEcCtD
Isradipine—Connective tissue disorder—Doxorubicin—bone cancer	0.000354	0.00322	CcSEcCtD
Isradipine—Angiopathy—Epirubicin—bone cancer	0.000353	0.00322	CcSEcCtD
Isradipine—Urethral disorder—Doxorubicin—bone cancer	0.000353	0.00322	CcSEcCtD
Isradipine—Immune system disorder—Epirubicin—bone cancer	0.000351	0.0032	CcSEcCtD
Isradipine—Mediastinal disorder—Epirubicin—bone cancer	0.000351	0.0032	CcSEcCtD
Isradipine—Back pain—Methotrexate—bone cancer	0.00035	0.00319	CcSEcCtD
Isradipine—Visual impairment—Doxorubicin—bone cancer	0.000347	0.00316	CcSEcCtD
Isradipine—Vomiting—Cisplatin—bone cancer	0.000342	0.00312	CcSEcCtD
Isradipine—Vision blurred—Methotrexate—bone cancer	0.000341	0.00311	CcSEcCtD
Isradipine—Mental disorder—Epirubicin—bone cancer	0.000341	0.00311	CcSEcCtD
Isradipine—Rash—Cisplatin—bone cancer	0.000339	0.00309	CcSEcCtD
Isradipine—Dermatitis—Cisplatin—bone cancer	0.000339	0.00309	CcSEcCtD
Isradipine—Malnutrition—Epirubicin—bone cancer	0.000339	0.00309	CcSEcCtD
Isradipine—Eye disorder—Doxorubicin—bone cancer	0.000336	0.00307	CcSEcCtD
Isradipine—Ill-defined disorder—Methotrexate—bone cancer	0.000336	0.00306	CcSEcCtD
Isradipine—Anaemia—Methotrexate—bone cancer	0.000334	0.00305	CcSEcCtD
Isradipine—Flushing—Doxorubicin—bone cancer	0.000334	0.00304	CcSEcCtD
Isradipine—Cardiac disorder—Doxorubicin—bone cancer	0.000334	0.00304	CcSEcCtD
Isradipine—Tension—Epirubicin—bone cancer	0.000332	0.00303	CcSEcCtD
Isradipine—Nervousness—Epirubicin—bone cancer	0.000329	0.003	CcSEcCtD
Isradipine—Back pain—Epirubicin—bone cancer	0.000328	0.00299	CcSEcCtD
Isradipine—Angiopathy—Doxorubicin—bone cancer	0.000327	0.00298	CcSEcCtD
Isradipine—Malaise—Methotrexate—bone cancer	0.000326	0.00297	CcSEcCtD
Isradipine—Muscle spasms—Epirubicin—bone cancer	0.000326	0.00297	CcSEcCtD
Isradipine—Immune system disorder—Doxorubicin—bone cancer	0.000325	0.00296	CcSEcCtD
Isradipine—Mediastinal disorder—Doxorubicin—bone cancer	0.000324	0.00296	CcSEcCtD
Isradipine—Leukopenia—Methotrexate—bone cancer	0.000324	0.00295	CcSEcCtD
Isradipine—Nausea—Cisplatin—bone cancer	0.00032	0.00291	CcSEcCtD
Isradipine—Vision blurred—Epirubicin—bone cancer	0.000319	0.00291	CcSEcCtD
Isradipine—Cough—Methotrexate—bone cancer	0.000316	0.00288	CcSEcCtD
Isradipine—Mental disorder—Doxorubicin—bone cancer	0.000315	0.00287	CcSEcCtD
Isradipine—Ill-defined disorder—Epirubicin—bone cancer	0.000314	0.00286	CcSEcCtD
Isradipine—Malnutrition—Doxorubicin—bone cancer	0.000313	0.00286	CcSEcCtD
Isradipine—Anaemia—Epirubicin—bone cancer	0.000313	0.00285	CcSEcCtD
Isradipine—Arthralgia—Methotrexate—bone cancer	0.000308	0.00281	CcSEcCtD
Isradipine—Chest pain—Methotrexate—bone cancer	0.000308	0.00281	CcSEcCtD
Isradipine—Tension—Doxorubicin—bone cancer	0.000307	0.0028	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000306	0.00279	CcSEcCtD
Isradipine—Malaise—Epirubicin—bone cancer	0.000305	0.00278	CcSEcCtD
Isradipine—Discomfort—Methotrexate—bone cancer	0.000304	0.00277	CcSEcCtD
Isradipine—Nervousness—Doxorubicin—bone cancer	0.000304	0.00277	CcSEcCtD
Isradipine—Syncope—Epirubicin—bone cancer	0.000304	0.00277	CcSEcCtD
Isradipine—Leukopenia—Epirubicin—bone cancer	0.000303	0.00276	CcSEcCtD
Isradipine—Back pain—Doxorubicin—bone cancer	0.000303	0.00276	CcSEcCtD
Isradipine—Muscle spasms—Doxorubicin—bone cancer	0.000301	0.00275	CcSEcCtD
Isradipine—Palpitations—Epirubicin—bone cancer	0.000299	0.00273	CcSEcCtD
Isradipine—Loss of consciousness—Epirubicin—bone cancer	0.000298	0.00271	CcSEcCtD
Isradipine—Cough—Epirubicin—bone cancer	0.000296	0.00269	CcSEcCtD
Isradipine—Anaphylactic shock—Methotrexate—bone cancer	0.000295	0.00269	CcSEcCtD
Isradipine—Vision blurred—Doxorubicin—bone cancer	0.000295	0.00269	CcSEcCtD
Isradipine—Ill-defined disorder—Doxorubicin—bone cancer	0.000291	0.00265	CcSEcCtD
Isradipine—Nervous system disorder—Methotrexate—bone cancer	0.00029	0.00264	CcSEcCtD
Isradipine—Anaemia—Doxorubicin—bone cancer	0.00029	0.00264	CcSEcCtD
Isradipine—Thrombocytopenia—Methotrexate—bone cancer	0.000289	0.00264	CcSEcCtD
Isradipine—Chest pain—Epirubicin—bone cancer	0.000288	0.00263	CcSEcCtD
Isradipine—Arthralgia—Epirubicin—bone cancer	0.000288	0.00263	CcSEcCtD
Isradipine—Anxiety—Epirubicin—bone cancer	0.000287	0.00262	CcSEcCtD
Isradipine—Skin disorder—Methotrexate—bone cancer	0.000287	0.00261	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000286	0.00261	CcSEcCtD
Isradipine—Hyperhidrosis—Methotrexate—bone cancer	0.000286	0.0026	CcSEcCtD
Isradipine—Discomfort—Epirubicin—bone cancer	0.000285	0.0026	CcSEcCtD
Isradipine—Malaise—Doxorubicin—bone cancer	0.000283	0.00258	CcSEcCtD
Isradipine—Dry mouth—Epirubicin—bone cancer	0.000282	0.00257	CcSEcCtD
Isradipine—Syncope—Doxorubicin—bone cancer	0.000281	0.00256	CcSEcCtD
Isradipine—Leukopenia—Doxorubicin—bone cancer	0.00028	0.00256	CcSEcCtD
Isradipine—Palpitations—Doxorubicin—bone cancer	0.000277	0.00252	CcSEcCtD
Isradipine—Oedema—Epirubicin—bone cancer	0.000276	0.00252	CcSEcCtD
Isradipine—Anaphylactic shock—Epirubicin—bone cancer	0.000276	0.00252	CcSEcCtD
Isradipine—Hypotension—Methotrexate—bone cancer	0.000276	0.00252	CcSEcCtD
Isradipine—Loss of consciousness—Doxorubicin—bone cancer	0.000275	0.00251	CcSEcCtD
Isradipine—Cough—Doxorubicin—bone cancer	0.000273	0.00249	CcSEcCtD
Isradipine—Shock—Epirubicin—bone cancer	0.000272	0.00248	CcSEcCtD
Isradipine—Nervous system disorder—Epirubicin—bone cancer	0.000271	0.00247	CcSEcCtD
Isradipine—Thrombocytopenia—Epirubicin—bone cancer	0.000271	0.00247	CcSEcCtD
Isradipine—Tachycardia—Epirubicin—bone cancer	0.00027	0.00246	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000269	0.00245	CcSEcCtD
Isradipine—Skin disorder—Epirubicin—bone cancer	0.000268	0.00245	CcSEcCtD
Isradipine—Hyperhidrosis—Epirubicin—bone cancer	0.000267	0.00244	CcSEcCtD
Isradipine—Insomnia—Methotrexate—bone cancer	0.000267	0.00243	CcSEcCtD
Isradipine—Arthralgia—Doxorubicin—bone cancer	0.000267	0.00243	CcSEcCtD
Isradipine—Chest pain—Doxorubicin—bone cancer	0.000267	0.00243	CcSEcCtD
Isradipine—Anxiety—Doxorubicin—bone cancer	0.000266	0.00242	CcSEcCtD
Isradipine—Paraesthesia—Methotrexate—bone cancer	0.000265	0.00242	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000265	0.00241	CcSEcCtD
Isradipine—Discomfort—Doxorubicin—bone cancer	0.000264	0.0024	CcSEcCtD
Isradipine—Dyspnoea—Methotrexate—bone cancer	0.000263	0.0024	CcSEcCtD
Isradipine—Somnolence—Methotrexate—bone cancer	0.000263	0.00239	CcSEcCtD
Isradipine—Dry mouth—Doxorubicin—bone cancer	0.000261	0.00238	CcSEcCtD
Isradipine—Dyspepsia—Methotrexate—bone cancer	0.00026	0.00237	CcSEcCtD
Isradipine—Hypotension—Epirubicin—bone cancer	0.000258	0.00235	CcSEcCtD
Isradipine—Decreased appetite—Methotrexate—bone cancer	0.000257	0.00234	CcSEcCtD
Isradipine—Anaphylactic shock—Doxorubicin—bone cancer	0.000256	0.00233	CcSEcCtD
Isradipine—Oedema—Doxorubicin—bone cancer	0.000256	0.00233	CcSEcCtD
Isradipine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000255	0.00232	CcSEcCtD
Isradipine—Fatigue—Methotrexate—bone cancer	0.000255	0.00232	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000252	0.0023	CcSEcCtD
Isradipine—Shock—Doxorubicin—bone cancer	0.000252	0.00229	CcSEcCtD
Isradipine—Nervous system disorder—Doxorubicin—bone cancer	0.000251	0.00229	CcSEcCtD
Isradipine—Thrombocytopenia—Doxorubicin—bone cancer	0.00025	0.00228	CcSEcCtD
Isradipine—Insomnia—Epirubicin—bone cancer	0.00025	0.00228	CcSEcCtD
Isradipine—Tachycardia—Doxorubicin—bone cancer	0.00025	0.00227	CcSEcCtD
Isradipine—Skin disorder—Doxorubicin—bone cancer	0.000248	0.00226	CcSEcCtD
Isradipine—Paraesthesia—Epirubicin—bone cancer	0.000248	0.00226	CcSEcCtD
Isradipine—Hyperhidrosis—Doxorubicin—bone cancer	0.000247	0.00225	CcSEcCtD
Isradipine—Dyspnoea—Epirubicin—bone cancer	0.000246	0.00225	CcSEcCtD
Isradipine—Somnolence—Epirubicin—bone cancer	0.000246	0.00224	CcSEcCtD
Isradipine—Feeling abnormal—Methotrexate—bone cancer	0.000243	0.00222	CcSEcCtD
Isradipine—Dyspepsia—Epirubicin—bone cancer	0.000243	0.00222	CcSEcCtD
Isradipine—Decreased appetite—Epirubicin—bone cancer	0.00024	0.00219	CcSEcCtD
Isradipine—Hypotension—Doxorubicin—bone cancer	0.000239	0.00218	CcSEcCtD
Isradipine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000239	0.00217	CcSEcCtD
Isradipine—Fatigue—Epirubicin—bone cancer	0.000238	0.00217	CcSEcCtD
Isradipine—Constipation—Epirubicin—bone cancer	0.000236	0.00215	CcSEcCtD
Isradipine—Urticaria—Methotrexate—bone cancer	0.000235	0.00214	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000233	0.00212	CcSEcCtD
Isradipine—Insomnia—Doxorubicin—bone cancer	0.000231	0.00211	CcSEcCtD
Isradipine—Paraesthesia—Doxorubicin—bone cancer	0.00023	0.00209	CcSEcCtD
Isradipine—Dyspnoea—Doxorubicin—bone cancer	0.000228	0.00208	CcSEcCtD
Isradipine—Feeling abnormal—Epirubicin—bone cancer	0.000228	0.00208	CcSEcCtD
Isradipine—Somnolence—Doxorubicin—bone cancer	0.000227	0.00207	CcSEcCtD
Isradipine—Dyspepsia—Doxorubicin—bone cancer	0.000225	0.00205	CcSEcCtD
Isradipine—Decreased appetite—Doxorubicin—bone cancer	0.000222	0.00203	CcSEcCtD
Isradipine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000221	0.00201	CcSEcCtD
Isradipine—Fatigue—Doxorubicin—bone cancer	0.00022	0.00201	CcSEcCtD
Isradipine—Urticaria—Epirubicin—bone cancer	0.00022	0.002	CcSEcCtD
Isradipine—Constipation—Doxorubicin—bone cancer	0.000219	0.00199	CcSEcCtD
Isradipine—Asthenia—Methotrexate—bone cancer	0.000212	0.00193	CcSEcCtD
Isradipine—Feeling abnormal—Doxorubicin—bone cancer	0.000211	0.00192	CcSEcCtD
Isradipine—Pruritus—Methotrexate—bone cancer	0.000209	0.0019	CcSEcCtD
Isradipine—Urticaria—Doxorubicin—bone cancer	0.000203	0.00185	CcSEcCtD
Isradipine—Diarrhoea—Methotrexate—bone cancer	0.000202	0.00184	CcSEcCtD
Isradipine—Asthenia—Epirubicin—bone cancer	0.000198	0.00181	CcSEcCtD
Isradipine—Pruritus—Epirubicin—bone cancer	0.000196	0.00178	CcSEcCtD
Isradipine—Dizziness—Methotrexate—bone cancer	0.000195	0.00178	CcSEcCtD
Isradipine—Diarrhoea—Epirubicin—bone cancer	0.000189	0.00172	CcSEcCtD
Isradipine—Vomiting—Methotrexate—bone cancer	0.000188	0.00171	CcSEcCtD
Isradipine—Rash—Methotrexate—bone cancer	0.000186	0.0017	CcSEcCtD
Isradipine—Dermatitis—Methotrexate—bone cancer	0.000186	0.0017	CcSEcCtD
Isradipine—Headache—Methotrexate—bone cancer	0.000185	0.00169	CcSEcCtD
Isradipine—Asthenia—Doxorubicin—bone cancer	0.000183	0.00167	CcSEcCtD
Isradipine—Dizziness—Epirubicin—bone cancer	0.000183	0.00167	CcSEcCtD
Isradipine—Pruritus—Doxorubicin—bone cancer	0.000181	0.00165	CcSEcCtD
Isradipine—Vomiting—Epirubicin—bone cancer	0.000176	0.0016	CcSEcCtD
Isradipine—Nausea—Methotrexate—bone cancer	0.000175	0.0016	CcSEcCtD
Isradipine—Diarrhoea—Doxorubicin—bone cancer	0.000175	0.00159	CcSEcCtD
Isradipine—Rash—Epirubicin—bone cancer	0.000174	0.00159	CcSEcCtD
Isradipine—Dermatitis—Epirubicin—bone cancer	0.000174	0.00159	CcSEcCtD
Isradipine—Headache—Epirubicin—bone cancer	0.000173	0.00158	CcSEcCtD
Isradipine—Dizziness—Doxorubicin—bone cancer	0.000169	0.00154	CcSEcCtD
Isradipine—Nausea—Epirubicin—bone cancer	0.000164	0.0015	CcSEcCtD
Isradipine—Vomiting—Doxorubicin—bone cancer	0.000163	0.00148	CcSEcCtD
Isradipine—Rash—Doxorubicin—bone cancer	0.000161	0.00147	CcSEcCtD
Isradipine—Dermatitis—Doxorubicin—bone cancer	0.000161	0.00147	CcSEcCtD
Isradipine—Headache—Doxorubicin—bone cancer	0.00016	0.00146	CcSEcCtD
Isradipine—Nausea—Doxorubicin—bone cancer	0.000152	0.00138	CcSEcCtD
